(MedPage Today) — High-flow oxygen didn’t help patients survive acute hypoxemic respiratory failure better than standard oxygen, the SOHO trial showed.
Mortality at day 28 came out an identical 14.6% in patients randomized to either treatment…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
